Previous Close | 10.12 |
Open | 10.04 |
Bid | 0.00 x 1200 |
Ask | 0.00 x 1100 |
Day's Range | 9.68 - 10.20 |
52 Week Range | 6.40 - 15.87 |
Volume | |
Avg. Volume | 386,125 |
Market Cap | 578.749M |
Beta (5Y Monthly) | 1.30 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.93 |
Earnings Date | Nov 06, 2023 - Nov 10, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 15.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for HCAT
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that two technologies, Health Catalyst Pop Analyzer™ and Health Catalyst Care Flow™, have achieved National Committee for Quality Assurance (NCQA) Prevalidation for Population Health Management in 2023.
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Health Catalyst was recognized in the latest Gartner Hype Cycle for Healthcare Providers, 2023 (July 2023); Hype Cycle for Healthcare Data, Analytics and AI, 2023 (July 2023); Hype Cycle for Digital Care Delivery Including Virtual Care, 2023 (July 2023); Hype Cycle for Real-Time Health System Technologies, 2023 (July 2023) and
SALT LAKE CITY, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of Investor Relations and FP&A, will participate in the Wells Fargo Healthcare Conference, being held in Boston, including a fireside chat presentation on Thursday, September 7, 2023 at 3:45pm EST. About